Get the Stockscreener App
37.64
0.92%
-0.35
Surmodics Inc stock is traded at $37.64, with a volume of 289.55K.
It is down -0.92% in the last 24 hours and up +19.91% over the past month.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
See More
Previous Close:
$37.99
Open:
$37.75
24h Volume:
289.55K
Relative Volume:
2.26
Market Cap:
$538.22M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
99.05
EPS:
0.38
Net Cash Flow:
$9.86M
1W Performance:
+7.51%
1M Performance:
+19.91%
6M Performance:
+10.38%
1Y Performance:
-4.25%
1-Day Range:
$36.86
$38.23
1-Week Range:
$35.00
$38.50
52-Week Range:
$26.00
$40.38
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
37.64 | 543.17M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
129.28 | 225.22B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.15 | 151.88B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.52 | 144.88B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
91.98 | 119.04B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.18 | 45.61B | 5.69B | 1.41B | 577.90M | 6.95 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Upgrade | Lake Street | Hold → Buy |
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
FTC Skeptical Of 'Partial' Sale For GTCR Merger Fix - Law360
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts - TradingView
GTCR-Surmodics divestiture to be evaluated by FTC by Aug. 15, US court told - MLex
What is the target price for Surmodics Inc. stockPrice Volume Breakout Screener - newsyoung.net
Is Surmodics Inc. exposed to political riskQuality Dividend Stock Finder - newsyoung.net
Surmodics (SRDX) Maintains Market Perform Rating by Barrington Research - AInvest
SurModics Maintains Hold Rating Amid Mixed Financial Performance and Ongoing Litigation - AInvest
Surmodics revenue down 3% to USD 29.6M in Q3 2025 - Medical Buyer
Surmodics 2025 Q3 Earnings Loss Narrows 29.6% - AInvest
SurModics' Strong Financials Offset by Acquisition Uncertainty - AInvest
SurModics: Fiscal Q3 Earnings Snapshot - Connecticut Post
Surmodics Lifts Guidance Despite Dips In Device Revenue - Finimize
GTCR, Surmodics file opposition to US FTC's motion for preliminary injunction - MLex
UPDATE: FTC request for GTCR/Surmodics divestiture docs denied - Global Competition Review
FTC seeks GTCR/Surmodics divestiture docs - Global Competition Review
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
SurModics earnings beat by $0.25, revenue topped estimates - Investing.com Canada
SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
SURMODICS INC SEC 10-Q Report - TradingView
Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance - Placera.se
Surmodics raises FY25 EPS view to (35c)-(20c) from (62c)-(42c) - TipRanks
SURMODICS Earnings Results: $SRDX Reports Quarterly Earnings - Quiver Quantitative
Medical device maker Surmodics's Q3 revenue dips 3%, FY guidance raised - MarketScreener
Surmodics (SRDX) Q3 EPS Turns Positive - AOL.com
Surmodics Reports Third Quarter Fiscal 2025 Financial Results - TradingView
What data driven models say about Surmodics Inc.’s futureDaily Trade Monitor with Pattern Alerts - Newser
Will Surmodics Inc. rebound enough to break evenRSI and MACD Signal Summary with Trends - Newser
Is Surmodics Inc. meeting your algorithmic filter criteriaAsset Growth Pattern and Return Summary - Newser
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - BioSpace
Press Release: Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - 富途牛牛
Is it the right time to buy Surmodics Inc. stockUnmatched profit growth - Jammu Links News
How does Surmodics Inc. generate profit in a changing economyAchieve breakthrough performance in the market - Jammu Links News
Why is Surmodics Inc. stock attracting strong analyst attentionUnlock superior stock analysis tools - Jammu Links News
When is Surmodics Inc. stock expected to show significant growthDiscover the fastest growing stocks today - Jammu Links News
How many analysts rate Surmodics Inc. as a “Buy”Massive stock growth - Jammu Links News
Surmodics Inc. Stock Analysis and ForecastFree Capital Allocation Plans - Jammu Links News
What is the risk reward ratio of investing in Surmodics Inc. stockOutstanding investment returns - Jammu Links News
Analyzing drawdowns of Surmodics Inc. with statistical toolsFree Day Trading Signals With High Precision - Newser
how surmodics inc. stock performs during market volatilityCapital Growth Plan for New Investors - Newser
Is Surmodics Inc. stock a growth or value playFree Step-by-Step Trade Signal Implementation - Newser
Is this a good reentry point in Surmodics Inc.Free Daily Growth Stock Pick Reports - Newser
What institutional investors are buying Surmodics Inc. stockExpert Picks Planner For Beginners - Jammu Links News
Volume Surge May Signal Institutional Interest in Surmodics Inc.Real Trader Watchlist of Hot Stocks Released - metal.it
Is a relief rally coming for Surmodics Inc. holdersReal-Time Trade Insights Spark Market Reactions - metal.it
Surmodics falls as parties, FTC ask for extension of briefing schedule - Seeking Alpha
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.30%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):